Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2024-11-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
国泰君安证券股份有限公司关于盈康生命科技股份有限公司向特定对象发行股票之上市保荐书
Capital/Financing Update Classification · 95% confidence The document is a detailed underwriting and sponsorship report by Guotai Junan Securities Co., Ltd. regarding a specific share issuance by INKON Life Technology Co., Ltd. It includes extensive financial data, risk disclosures, issuance details such as pricing, number of shares, and regulatory compliance references. The document is titled as a "上市保荐书" which translates to "Listing Sponsorship Document" or "Sponsorship Letter" related to a specific targeted share issuance. This type of document is a formal underwriting and sponsorship report for a capital raising event, which fits the category of Capital/Financing Update (CAP). It is not an annual or interim report, nor an earnings release or proxy statement. It is a comprehensive document related to a specific financing event (private placement of shares). Therefore, the correct classification is CAP with high confidence.
2024-11-10 Chinese
北京市金杜律师事务所关于《盈康生命科技股份有限公司收购报告书》之法律意见书
M&A Activity Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding a company's acquisition report. It references the "收购报告书" (Acquisition Report) of 盈康生命科技股份有限公司 and discusses the legal aspects of a specific stock issuance to a particular party, including detailed information about the acquirer, their shareholders, and related entities. The document is focused on legal opinions related to a merger/acquisition transaction rather than financial results, management changes, or regulatory announcements. It is not an announcement or a brief notice but a substantive legal opinion document. Therefore, the document fits best into the category related to merger and acquisition activities.
2024-11-10 Chinese
盈康生命向特定对象发行股票上市公告书
Capital/Financing Update Classification · 100% confidence The document is titled as a "上市公告书" which translates to "Listing Announcement" or "Announcement of Stock Issuance and Listing." It details the issuance of new shares to specific investors, including the number of shares, pricing, subscription process, regulatory approvals, and listing arrangements. It includes detailed information about the issuance process, regulatory approvals from the China Securities Regulatory Commission and Shenzhen Stock Exchange, subscription funds verification, and the listing date of the new shares. The document is comprehensive and contains substantive financial and procedural data related to a capital raising event through a private placement or directed share issuance. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. It is not an Annual Report, Earnings Release, or Regulatory Filing, nor is it a simple announcement of a report publication. The document length and content confirm it is the actual detailed announcement of the capital raising event.
2024-11-10 Chinese
盈康生命收购报告书
M&A Activity Classification · 95% confidence The document is titled "盈康生命科技股份有限公司收购报告书" which translates to "Acquisition Report of Yingkang Life Technology Co., Ltd." The content includes detailed information about the acquirer, the acquisition purpose, shareholding structure before and after acquisition, legal compliance, funding sources, and related corporate governance matters. It references relevant laws such as the Company Law, Securities Law, and Acquisition Management Measures, indicating it is a formal acquisition disclosure document. The document is comprehensive and lengthy (15,000 characters), containing substantive information about the acquisition transaction rather than just an announcement or summary. This matches the definition of a M&A Activity (TAR) filing, which covers announcements and documents related to merger proposals or takeover bids. It is not a proxy statement, voting results, or a merger proxy form, but a detailed acquisition report. Therefore, the correct classification is TAR with high confidence.
2024-11-10 Chinese
上海荣正企业咨询服务（集团）股份有限公司关于盈康生命科技股份有限公司2023年限制性股票激励计划首次授予部分第一个归属期归属条件成就之独立财务顾问报告
Regulatory Filings Classification · 95% confidence The document is an independent financial advisor report regarding the 2023 restricted stock incentive plan of Yingkang Life Technology Co., Ltd. It details the approval procedures, achievement of vesting conditions, specific vesting details, and conclusions about the stock incentive plan. The content focuses on the stock incentive plan's vesting conditions and approvals, with no financial statements or earnings data. It is a specialized advisory report related to management compensation and stock incentives rather than a general management announcement or remuneration report. Given the nature of the document as an independent financial advisor's report on a stock incentive plan, it fits best under the category of Regulatory Filings (RNS) as it does not match other more specific categories like Remuneration Information (DEF 14A) which typically detail executive compensation broadly, nor is it a full Annual Report or Earnings Release. The document is substantive and not a mere announcement, so RPA is excluded. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-11-08 Chinese
第六届监事会第十一次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th (extraordinary) meeting of the 6th Supervisory Board of Yingkang Life Technology Co., Ltd. It details the meeting's convening, attendance, and voting results on matters related to the 2023 restricted stock incentive plan, including approval of the first vesting period conditions and cancellation of some unvested restricted shares. The document is an official meeting resolution announcement rather than a full report or financial statement. It does not contain financial data or detailed analysis but rather the outcomes of supervisory board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies. The document length is short and focused on meeting resolutions, not a full report or regulatory filing. Therefore, the best classification is MANG with high confidence.
2024-11-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.